Overview

Efficacy and Safety Study of Ozanimod in Ulcerative Colitis

Status:
Completed
Trial end date:
2019-08-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether RPC1063 is effective in the treatment of ulcerative colitis (UC).
Phase:
Phase 2
Details
Lead Sponsor:
Celgene
Treatments:
Ozanimod